Psilocybin in Cancer Pain Study
Psilocybin in Cancer Pain Study
Recruiting · NCT06001749 · Registry updated 2026-08-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Psilocybin in Cancer Pain Study | Chemically-Induced Disorders, Narcotic-Related Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, agnosia, nervous system disorder, opiate dependence, perceptual disorders, psychiatric disorder, substance-related disorder | Recruiting | Phase 2 | 2026-08-05 | NCT06001749 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cy Biopharma | 1 |
| Pancreatic Cancer North America | 1 |
| Yvan Beaussant, MD, MSci | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | United States | 626 |